Protective effects of miR-24-2-5p in early stages of breast cancer bone metastasis.

Saved in:
Bibliographic Details
Title: Protective effects of miR-24-2-5p in early stages of breast cancer bone metastasis.
Authors: Puppo M; Research Unit UMR_S1033, LyOS, Faculty of Medicine Lyon-Est, INSERM, 7 Rue Guillaume Paradin, Lyon, 69372, France. margherita.puppo@gmail.com.; Université Claude Bernard Lyon 1, Villeurbanne, France. margherita.puppo@gmail.com.; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK. margherita.puppo@gmail.com., Croset M; Research Unit UMR_S1033, LyOS, Faculty of Medicine Lyon-Est, INSERM, 7 Rue Guillaume Paradin, Lyon, 69372, France.; Université Claude Bernard Lyon 1, Villeurbanne, France., Ceresa D; IRCCS Ospedale Policlinico San Martino, Genova, Italy., Valluru MK; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK., Canuas Landero VG; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK., Hernandez Guadarrama M; Research Unit UMR_S1033, LyOS, Faculty of Medicine Lyon-Est, INSERM, 7 Rue Guillaume Paradin, Lyon, 69372, France.; Université Claude Bernard Lyon 1, Villeurbanne, France., Iuliani M; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, Roma, 200 - 00128, Italy.; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, Roma, 21 - 00128, Italy., Pantano F; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, Roma, 200 - 00128, Italy.; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, Roma, 21 - 00128, Italy., Dawn Ottewell P; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK., Clézardin P; Research Unit UMR_S1033, LyOS, Faculty of Medicine Lyon-Est, INSERM, 7 Rue Guillaume Paradin, Lyon, 69372, France. philippe.clezardin@inserm.fr.; Université Claude Bernard Lyon 1, Villeurbanne, France. philippe.clezardin@inserm.fr.; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK. philippe.clezardin@inserm.fr.
Source: Breast cancer research : BCR [Breast Cancer Res] 2024 Dec 18; Vol. 26 (1), pp. 186. Date of Electronic Publication: 2024 Dec 18.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39696397
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Protective effects of miR-24-2-5p in early stages of breast cancer bone metastasis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Puppo+M%22">Puppo M</searchLink>; Research Unit UMR_S1033, LyOS, Faculty of Medicine Lyon-Est, INSERM, 7 Rue Guillaume Paradin, Lyon, 69372, France. margherita.puppo@gmail.com.; Université Claude Bernard Lyon 1, Villeurbanne, France. margherita.puppo@gmail.com.; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK. margherita.puppo@gmail.com.<br /><searchLink fieldCode="AU" term="%22Croset+M%22">Croset M</searchLink>; Research Unit UMR_S1033, LyOS, Faculty of Medicine Lyon-Est, INSERM, 7 Rue Guillaume Paradin, Lyon, 69372, France.; Université Claude Bernard Lyon 1, Villeurbanne, France.<br /><searchLink fieldCode="AU" term="%22Ceresa+D%22">Ceresa D</searchLink>; IRCCS Ospedale Policlinico San Martino, Genova, Italy.<br /><searchLink fieldCode="AU" term="%22Valluru+MK%22">Valluru MK</searchLink>; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Canuas+Landero+VG%22">Canuas Landero VG</searchLink>; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Hernandez+Guadarrama+M%22">Hernandez Guadarrama M</searchLink>; Research Unit UMR_S1033, LyOS, Faculty of Medicine Lyon-Est, INSERM, 7 Rue Guillaume Paradin, Lyon, 69372, France.; Université Claude Bernard Lyon 1, Villeurbanne, France.<br /><searchLink fieldCode="AU" term="%22Iuliani+M%22">Iuliani M</searchLink>; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, Roma, 200 - 00128, Italy.; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, Roma, 21 - 00128, Italy.<br /><searchLink fieldCode="AU" term="%22Pantano+F%22">Pantano F</searchLink>; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, Roma, 200 - 00128, Italy.; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, Roma, 21 - 00128, Italy.<br /><searchLink fieldCode="AU" term="%22Dawn+Ottewell+P%22">Dawn Ottewell P</searchLink>; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Clézardin+P%22">Clézardin P</searchLink>; Research Unit UMR_S1033, LyOS, Faculty of Medicine Lyon-Est, INSERM, 7 Rue Guillaume Paradin, Lyon, 69372, France. philippe.clezardin@inserm.fr.; Université Claude Bernard Lyon 1, Villeurbanne, France. philippe.clezardin@inserm.fr.; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK. philippe.clezardin@inserm.fr.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100927353%22">Breast cancer research : BCR</searchLink> [Breast Cancer Res] 2024 Dec 18; Vol. 26 (1), pp. 186. <i>Date of Electronic Publication: </i>2024 Dec 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central+Ltd%22">BioMed Central Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100927353 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1465-542X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214655411%22">14655411 </searchLink><i>NLM ISO Abbreviation: </i>Breast Cancer Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39696397
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s13058-024-01934-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 186
    Titles:
      – TitleFull: Protective effects of miR-24-2-5p in early stages of breast cancer bone metastasis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Puppo M
      – PersonEntity:
          Name:
            NameFull: Croset M
      – PersonEntity:
          Name:
            NameFull: Ceresa D
      – PersonEntity:
          Name:
            NameFull: Valluru MK
      – PersonEntity:
          Name:
            NameFull: Canuas Landero VG
      – PersonEntity:
          Name:
            NameFull: Hernandez Guadarrama M
      – PersonEntity:
          Name:
            NameFull: Iuliani M
      – PersonEntity:
          Name:
            NameFull: Pantano F
      – PersonEntity:
          Name:
            NameFull: Dawn Ottewell P
      – PersonEntity:
          Name:
            NameFull: Clézardin P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 12
              Text: 2024 Dec 18
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1465-542X
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Breast cancer research : BCR
              Type: main
ResultId 1